Inflammation: Its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics

Psychopharmacology

Volumn 231, Issue 2, 2014, Pages 317-318

  Mondelli, Valeria ^a   Howes, Oliver ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; CELL ACTIVATION; CELL COUNT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EDITORIAL; IMMUNOREACTIVITY; INFLAMMATION; MICROGLIA; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; TREATMENT DURATION; WEIGHT GAIN; COMPLICATION; HUMAN;

ANTI-INFLAMMATORY AGENTS; ANTIPSYCHOTIC AGENTS; HUMANS; INFLAMMATION; SCHIZOPHRENIA;

EID: 84892787038     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3383-3     Document Type: Editorial

References (15)

1. Di Nicola M, Cattaneo A, Hepgul N, Di Forti M, Aitchison KJ, Janiri L, Murray RM, Dazzan P, Pariante CM, Mondelli V (2013) Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav Immun 31:90-95
2. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50:1801-1807
3. Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137-162
4. Howes OD, Bhatnagar A, Gaughran FP, Amiel SA, Murray RM, Pilowsky LS (2004) A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance. Am J Psychiatr 161:361-363
5. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663-671
6. Mondelli V, Cattaneo A, Belvederi Murri M, Di Forti M, Handley R, Hepgul N, Miorelli A, Navari S, Papadopoulos AS, Aitchison KJ, Morgan C, Murray RM, Dazzan P, Pariante CM (2011) Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry 72:1677-1684
7. Mondelli V, Anacker C, Vernon AC, Cattaneo A, Natesan S, Modo M, Dazzan P, Kapur S, Pariante CM (2013) Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways. Transl Psychiatry 3:e208
8. Nitta M, Kishimoto T, Muller N, Weiser M, Davidson M, Kane JM, Correll CU (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230-1241
9. Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J, Guo XF, Wu RR, Zhao JP (2013) Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Psychopharmacology 225:627-635
10. Poyurovsky M, Fuchs C, Pashinian A, Levi A, Weizman R, Weizman A (2013) Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination. Psychopharmacology 226:615-622
11. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31-41
12. Schnieder TP, Dwork AJ (2011) Searching for neuropathology: gliosis in schizophrenia. Biol Psychiatry 69:134-139
13. Song X, Fan X, Li X, Zhang W, Gao J, Zhao J, Harrington A, Ziedonis D, Lv L (2013). Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first episode schizophrenia. Psychopharmacology. doi: 10.1007/s00213-013-3382-4
14. van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820-822
15. Zajkowska Z, Mondelli V (2013) First episode psychosis: an inflammatory state? NeuroImmunoModulation. doi: 10.1159/000356536